Replies to post #212405 on Biotech Values

[DewDiligence]

Re: PD-(L)1-refractory market

…no one including BMY has insider track to capture that market yet.

I didn’t claim anybody had an inside track, but rather that the PD-(L)1-refractory market is going to become a material portion of the overall I-O market and that many investors appear to be overlooking the opportunity.

BMY is pursuing various ideas—e.g. #msg-131892692.